CENTOGENE - transforming genetic data into medical decisions. We are the worldwide leader in the field of early genetic diagnostics for rare hereditary diseases. A database of genetic data from over 110 countries gives us a unique access to epidemiological, clinical and genetic information on hereditary disorders, including oncogenetic indications.
We focus exclusively on providing the highest quality, patient-centred service, verified by multiple international accreditations (ISO, CAP, CLIA), regular pharmaceutical audits and our outstanding short turn-around times for analysis. Our medical expertise is based on cutting-edge technologies including whole exome/genome sequencing, innovative biomarkers and continued R&D. Our mutation database (CentoMD¨) is the worldÕs largest for rare genetic diseases and is pivotal to our high-quality diagnostic reporting and comprehensive medical interpretation. CENTOGENE is a key partner for many high-profile pharmaceutical companies who are active in the orphan drug development.
Imprint
CENTOGENE AG is a stock corporation ('Aktiengesellschaft') incorporated under the laws of the Federal Republic of Germany with registered seat in Rostock. It is registered with the commercial register of the local court ('Amtsgericht') of Rostock under HRB 13225.
CENTOGENE AG is CAP (# 8005167) accredited and CLIA (# 99D2049715) registered.
Chairman of the Supervisory Board: Dr. Hubert Birner
Executive Board authorized to represent the company: Prof. Dr. Arndt Rolfs (CEO), Richard Stoffelen (CFO), Prof. Dr. Peter Bauer (CSO), Dr. Volkmar Weckesser (CIO)
CENTOGENE AG
Schillingallee 68
18057 Rostock
Germany
Tel.: +49 381-203652-0
Fax: +49 381-203652-19
Email: press(at)centogene(dot)com
The Value Added Tax (VAT) identification number (pursuant to Article 22 (1) of the Sixth Council Directive (77/388/EEC) of 17 May 1977 on the harmonization of the laws of the Member States of the European Union relating to turnover taxes) is DE813228872.
- Company Name:Centogene Ag
(View Trends)
-
Headquarters: (View Map)Rostock, Germany
-
Biotechnology
-
200 - 500 employees
- 75115 Global Rank
- 5338 Germany
- 886 K Estimated Visits
-
Search48.60%
-
Direct39.00%
-
Referrals9.16%
-
Display1.37%
-
Mail1.29%
-
Social0.57%
-
70.18%
-
4.67%
-
4.38%
-
1.47%
-
1.40%
- 10 SDKs
- 3.4 Avg. Rating
- App Url: https://itunes.apple.com/app/centogene-ag/id1435899934
- App Support: https://www.centogene.com/contact.html
- Genre: Medical
- Bundle ID: com.centogene.myLSDApp
- App Size: 46.5 M
- Version: 2.1.3
- Release Date: December 6th, 2018
- Update Date: April 22nd, 2021
Description:
This application is intended exclusively for the use of Gaucher disease patients or their caregivers
myLSDapp is an easy-to-use health counseling platform designed to automate care coordination and support improvement of health outcomes while promoting patient participation.
Discover how medical caregivers can track patient quality of life measures. Designed by world known rare disease experts specializing in Lysosomal Storage Disorders diseases (i.e. Gaucher, Fabry, Hunter).
Connected with our professional platform, myLSDapp provides an integrated system that supports care coordination between physicians and their patients or may limit you to just completing surveys and assessments depending on the individual preferences.
myLSDapp for individuals provides personal health data tracking, survey completion and daily care reminders for improved health outcomes.
myLSDapp was designed to track information about Gaucher Disease with a few screen taps. This will allow you to take control of your disease. myLSDapp makes it easy to perform tasks like tracking your treatment progress and recording your well being on a daily basis.
Main characteristics are:
• LysoGb1 biomarker test results
myLSDapp saves time by automatically providing reported test results of LysoGb1 marker directly to your smartphone. Usage of this feature is secured and enabled only to authorized users.
The app allows you to store the results of your laboratory tests relevant for Gaucher condition. The color indicators in the app usefully show if the quality of your test result. To verify the results of lab tests, always consult with your doctor!
• Daily Quality of life tracker
Reach your health goals by documenting and tracking your well being. Complete regularly surveys that are relevant for Gaucher diagnosed patients. Studies show that monitoring and tracking progress increases your likelihood of meeting your goals.
• Track your treatment
It is easy to lose track having long treatment history. Use our Treatment section designed to track Gaucher specific treatments. Enter, document, and track as much or as little information as you want with a few screen taps.
• Communication with Physician
If you have myLSD app it's simple to share your information with chosen physician. Just connect to them through the app. The integrated contact function allows you to communicate quickly and easily with our laboratory. See for yourself!
• Data security
Sharing your information with physician of your choice has never been easier. By sharing your data with trusted physician, you can achieve better communication and health improvements. Sharing is entirely up to you.
Take advantage of myLSDapp’s great features until you can manage Gaucher disease better!
-
Native0%
-
Standard0%
They are headquartered at Rostock, Germany, and have 3 advertising & marketing contacts listed on Kochava. Centogene Ag works with Advertising technology companies such as LinkedIn Ads, DoubleClick.Net, AppNexus, AppNexus Segment Pixel, Bizo, Google Remarketing.
